TAp73β and DNp73β activate the expression of the pro-survival caspase-2S

Nucleic Acids Research

Volumn 36, Issue 13, 2008, Pages 4498-4509

  Toh, Wen Hong ^a   Logette, Emmanuelle ^b   Corcos, Laurent ^c   Sabapathy, Kanaga ^a,d,e  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^d DUKE NUS MEDICAL SCHOOL   (Singapore)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 2; DNA; PROTEIN P53; PROTEIN P63; PROTEIN P73; TRANSCRIPTION FACTOR SP1; DNA BINDING PROTEIN; ISOPROTEIN; NUCLEAR PROTEIN; TUMOR SUPPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN P73;

ARTICLE; BINDING SITE; CANCER GENETICS; CANCER RESISTANCE; CANCER SURVIVAL; CELL DEATH; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GC RICH SEQUENCE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MUTANT; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; TRANSACTIVATION; BIOSYNTHESIS; CELL LINE; GENE DELETION; GENETICS; METABOLISM;

BINDING SITES; CASPASE 2; CELL DEATH; CELL LINE; CELL SURVIVAL; DNA-BINDING PROTEINS; HUMANS; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; SEQUENCE DELETION; TRANS-ACTIVATION (GENETICS); TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 48349083376     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkn414     Document Type: Article

References (39)

1. Jost,C.A., Marin,M.C. and Kaelin,W.G. Jr. (1997) p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature, 389, 191-194.
2. Kaghad,M., Bonnet,H., Yang,A., Creancier,L., Biscan,J.C., Valent,A., Minty,A., Chalon,P., Lelias,J.M., Dumont,X. et al. (1997) Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell, 90, 809-819.
3. Stiewe,T., Zimmermann,S., Frilling,A., Esche,H. and Putzer,B.M. (2002) Transactivation-deficient DeltaTA-p73 acts as an oncogene. Cancer Res., 62, 3598-3602.
4. Stiewe,T., Theseling,C.C. and Putzer,H.M. (2002) Transactivation- deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: Implications for tumorigenesis. J. Biol. Chem., 277 14177-14185.
5. Liu G., Nozell,S., Yiao,H. and Chen,X. (2004) DeltaNp73beta is active in transactivation and growth suppression. Mol. Cell Biol., 24, 487-501.
6. Melino,G., De Laurenzi,V. and Vousden,K.H. (2002) p73: Friend or foe in tumorigenesis. Nat. Rev. Cancer, 2, 605-615.
7. Ueda,Y., Hijikata,M., Takagi,S., Chiba,T. and Shimotohno,K. (1999) New p73 variants with altered C-terminal structures have varied transcriptional activitiest Oncogene, 18, 4993-4998.
8. Lee,C.W. and La Thangue,N.B. (1999) Promoter specificity and stability control of the p53-rclated protein p73. Oncogene, 18, 4171-4181.
9. Flores,E.R., Tsai,K.Y., Crowley,D., Sengupta,S., Yang,A., McKeon,F. and Jacks,T. (2002) p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature, 416, 560-564.
10. Flores,E.R., Sengupta,S., Miller,J.B., Newman,J.J., Bronson,R., Crowley,D., Yang,A., McKeon,F. and Jacks,T. (2005) Tumor predisposition in mice mutant for p63 and p73: Evidence for broader tumor suppressor functions for the p53 family. Cancer Cell, 7, 363-373.
11. Becker,K., Pancoska,P., Concin,N., Vanden,H.K., Slade,N., Fischer,M., Chalas,E. and Moll,U.M. (2006) Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers. Int. J. Oncol., 29, 889-902.
12. Concin,N., Becker,K., Slade,N., Erster,S., Mueller-Holzner,E., Ulmer,H., Daxenbichler,G., Zeimet,A., Zeillinger,R., Marth,C. et al. (2004) Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo. Cancer Res., 64, 2449-2460.
13. Hong,S.M., Cho,H., Moskaluk,C.A., Yu,E. and Zaika,A.I. (2007) p63 and p73 expression in extrahepatic bile duct carcinoma and their clinical significance. J. Mol. Histol., 38, 167-175.
14. Kovalev,S., Marchenko,N., Swendeman,S., LaQuaglia,M. and Moll,U.M. (1998) Expression level, allelic origin, and mutation analysis of the p73 gene in neuroblastoma tumors and cell lines. Cell Growth Differ. 9, 897-903.
15. Zaika,A., Irwin M., Sansome,C. and Moll,U.M. (2001) Oncogenes induce and activate endogenous p73 protein. J. Biol. Chem., 276, 11310-11316.
16. Zaika,A.I., Kovalev,S., Marchenko,N.D. and Moll,U.M. (1999) Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. Cancer Res., 59, 3257-3263.
17. Zaika,A.I. and El-Rifai,W. (2006) The role of p53 protein family in gastrointestinal malignancies. Cell Death Differ., 13, 935-940.
18. Vikhanskaya,F., Toh,W.H., Dulloo,I., Wu,Q., Boominathan,L., Ng,H.H., Vousden,K.H. and Sabapathy,K. (2007) p73 supports cellular growth through c-Jun-dependent AP-1 transactivation. Nat. Cell Biol., 9, 698-706.
19. Tomkova,K., El-Rifai,W., Vilgelm,A., Kelly,M.C., Wang,T.C. and Zaika,A.I. (2006) The gastrin gene promoter is regulated by p73 isoforms in tumor cells. Oncogene, 25, 6032-6036.
20. Tomkova,K., Belkhiri,A., El-Rifai,W. and Zaika,A.-I. (2004) p73 isoforms can induce T-cell factor-dependent transcription in gastrointestinal cells. Cancer Res., 64, 6390-6393.
21. Toh,W.H., Kyo,S. and Sabapathy,K. (2005) Relief of p53- mediated telomerase suppression by p73. J. Biol. Chem., 280, 17329-17338.
22. Ramadan,S., Terrinoni,A., Catani,M.V., Sayan,A.E., Knight,R.A., Mueller,M., Krammer,P.H., Melino,G. and Candi,E. (2005) p73 induces apoptosis by different mechanisms. Biochem. Biophys. Res. Commun., 331, 713-717.
23. Pozniak,C.D., Radinovic,S., Yang,A., McKeon,F., Kaplan,D.R. and Miller,F.D. (2000) An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. Science, 289, 304-306.
24. Shi,Y. (2002) Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell, 9, 459-470.
25. Ramadan,S., Terrinoni,A., Catani,M.V., Sayan,A.E., Knight,R.A., Mueller,M., Krammer,P.H., Melino,G. and Candi,E. (2005) p73 induces apoptosis by different mechanisms. Biochem. Biophys. Res. Commun., 331, 713-717.
26. Kumar,S., Kinoshita,M., Noda,M., Copeland,N.G. and Jenkins,N.A. (1994) Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1. beta-converting enzyme. Genes Dev., 8, 1613-1626.
27. Wang,L., Miura,M., Bergeron,L., Zhu,H. and Yuan,J. (1994) Ich-1, an Ice/ ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell, 78, 739-750.
28. Logette,E., Wotawa,A., Solier,S., Desoche,L., Solary,E. and Corcos,L. (2003) The human caspase-2 gene: Alternative promoters, pre-mRNA splicing and AUG usage direct isoform-specific expression. Oncogene 22, 935-946.
29. Ishii,S., Kadonaga,J.T., Tjian,R., Brady,J.N., Merlino,G.T. and Pastan,I. (1986) inding of the Sp1 transcription factor by the human Harvey ras1 proto-oncogene promoter. Science, 232, 1410-1413.
30. Solier,S., Logette,E., Desoche,L., Solary,E. and Corcos,L. (2005) Nonsense-mediated mRNA decay among human caspases: The caspase-2S putative protein is encoded by an extremely short-lived mRNA. Cell Death Differ., 12, 687-689.
31. Kadonaga,J.T., Carner,K.R., Masiarz,F.R. and Tjian,R. (1987) Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell, 51, 1079-1090.
32. Irwin,M.S., Kondo,K., Marin,M.C., Cheng,L.S., Hahn,W.C. and Kaelin,W.G. Jr. (2003) Chemosensitivity linked to p73 function. Cancer Cell, 3, 403-410.
33. Yang,A., Walker,N., Bronson,R., Kaghad,M., Oosterwegel,M., Bonnin,J., Vagner,C., Bonnet,H., Dikkes,P., Sharpe,A. et al. (2000) p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours. Nature, 404, 99-103.
34. Lee,A.F., Ho,D.K., Zanassi,P., Walsh,G.S., Kaplan,D.R. and Miller,F.D. (2004) Evidence that DeltaNp73 promotes neuronal survival by p53-dependent and p53-independent mechanisms. J. Neurosci., 24 9174-9184.
35. Ito,A., Uehara,T. and Nomura,Y. (2000) Isolation of Ich-1S (caspase-2S)-binding protein that partially inhibits caspase activity. FEBS Lett., 470, 360-364.
36. Jacobs,W.B., Kaplan,D.R. and Miller,F.D. (2006) The p53 family in nervous system development and disease. J. Neurochem., 97, 1571-1584.
37. Liu,G. and Chen,X. (2005) The C-terminal sterile alpha motif and the extreme C terminus regulate the transcriptional activity of the alpha isoform of p73. J. Biol. Chem., 280, 20111-20119.
38. Wang,W.K., Bycroft,M., Foster,N.W., Buckle,A.M., Fersht,A.R. and Chen,Y.W. (2001) Structure of the C-terminal sterile alpha-motif (SAM) domain of human p73 alpha. Acta Crystallogr. D. Biol. Crystallogr. 57, 545-551.
39. Kartasheva,N.N., Lenz-Bauer,C., Hartmann,O., Schafer,H., Eilers,M. and Dobbelstein,M. (2003) DeltaNp73 can modulate the expression of various genes in a p53-independent fashion. Oncogene, 22, 8246-8254.